232 related articles for article (PubMed ID: 23965942)
1. Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis.
Chrabot BS; Kariuki SN; Zervou MI; Feng X; Arrington J; Jolly M; Boumpas DT; Reder AT; Goulielmos GN; Niewold TB
Genes Immun; 2013 Dec; 14(8):471-8. PubMed ID: 23965942
[TBL] [Abstract][Full Text] [Related]
2. Interferon regulatory factors in human lupus pathogenesis.
Salloum R; Niewold TB
Transl Res; 2011 Jun; 157(6):326-31. PubMed ID: 21575916
[TBL] [Abstract][Full Text] [Related]
3. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.
Niewold TB; Kelly JA; Kariuki SN; Franek BS; Kumar AA; Kaufman KM; Thomas K; Walker D; Kamp S; Frost JM; Wong AK; Merrill JT; Alarcón-Riquelme ME; Tikly M; Ramsey-Goldman R; Reveille JD; Petri MA; Edberg JC; Kimberly RP; Alarcón GS; Kamen DL; Gilkeson GS; Vyse TJ; James JA; Gaffney PM; Moser KL; Crow MK; Harley JB
Ann Rheum Dis; 2012 Mar; 71(3):463-8. PubMed ID: 22088620
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-α and serologic autoimmunity in lupus patients.
Robinson T; Kariuki SN; Franek BS; Kumabe M; Kumar AA; Badaracco M; Mikolaitis RA; Guerrero G; Utset TO; Drevlow BE; Zaacks LS; Grober JS; Cohen LM; Kirou KA; Crow MK; Jolly M; Niewold TB
J Immunol; 2011 Aug; 187(3):1298-303. PubMed ID: 21705624
[TBL] [Abstract][Full Text] [Related]
5. Association of IRF5 polymorphisms with increased risk for systemic lupus erythematosus in population of Crete, a southern-eastern European Greek island.
Zervou MI; Dorschner JM; Ghodke-Puranik Y; Boumpas DT; Niewold TB; Goulielmos GN
Gene; 2017 Apr; 610():9-14. PubMed ID: 28185859
[TBL] [Abstract][Full Text] [Related]
6. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.
Niewold TB; Kelly JA; Flesch MH; Espinoza LR; Harley JB; Crow MK
Arthritis Rheum; 2008 Aug; 58(8):2481-7. PubMed ID: 18668568
[TBL] [Abstract][Full Text] [Related]
7. Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production.
Chung SA; Taylor KE; Graham RR; Nititham J; Lee AT; Ortmann WA; Jacob CO; Alarcón-Riquelme ME; Tsao BP; Harley JB; Gaffney PM; Moser KL; ; Petri M; Demirci FY; Kamboh MI; Manzi S; Gregersen PK; Langefeld CD; Behrens TW; Criswell LA
PLoS Genet; 2011 Mar; 7(3):e1001323. PubMed ID: 21408207
[TBL] [Abstract][Full Text] [Related]
8. Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification.
Munroe ME; Lu R; Zhao YD; Fife DA; Robertson JM; Guthridge JM; Niewold TB; Tsokos GC; Keith MP; Harley JB; James JA
Ann Rheum Dis; 2016 Nov; 75(11):2014-2021. PubMed ID: 27088255
[TBL] [Abstract][Full Text] [Related]
9. Coordination between innate immune cells, type I IFNs and IRF5 drives SLE pathogenesis.
Matta B; Barnes BJ
Cytokine; 2020 Aug; 132():154731. PubMed ID: 31130331
[TBL] [Abstract][Full Text] [Related]
10. Interferon regulatory factor 3 as key element of the interferon signature in plasmacytoid dendritic cells from systemic lupus erythematosus patients: novel genetic associations in the Mexican mestizo population.
Santana-de Anda K; Gómez-Martín D; Monsivais-Urenda AE; Salgado-Bustamante M; González-Amaro R; Alcocer-Varela J
Clin Exp Immunol; 2014 Dec; 178(3):428-37. PubMed ID: 25130328
[TBL] [Abstract][Full Text] [Related]
11. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies.
Hua J; Kirou K; Lee C; Crow MK
Arthritis Rheum; 2006 Jun; 54(6):1906-16. PubMed ID: 16736505
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
13. Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers.
Chasset F; Ribi C; Trendelenburg M; Huynh-Do U; Roux-Lombard P; Courvoisier DS; Chizzolini C;
Rheumatology (Oxford); 2020 Nov; 59(11):3468-3478. PubMed ID: 32375176
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients.
Salloum R; Franek BS; Kariuki SN; Rhee L; Mikolaitis RA; Jolly M; Utset TO; Niewold TB
Arthritis Rheum; 2010 Feb; 62(2):553-61. PubMed ID: 20112359
[TBL] [Abstract][Full Text] [Related]
15. Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus.
Kariuki SN; Franek BS; Kumar AA; Arrington J; Mikolaitis RA; Utset TO; Jolly M; Crow MK; Skol AD; Niewold TB
Arthritis Res Ther; 2010; 12(4):R151. PubMed ID: 20659327
[TBL] [Abstract][Full Text] [Related]
16. A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5.
Sigurdsson S; Nordmark G; Garnier S; Grundberg E; Kwan T; Nilsson O; Eloranta ML; Gunnarsson I; Svenungsson E; Sturfelt G; Bengtsson AA; Jönsen A; Truedsson L; Rantapää-Dahlqvist S; Eriksson C; Alm G; Göring HH; Pastinen T; Syvänen AC; Rönnblom L
Hum Mol Genet; 2008 Sep; 17(18):2868-76. PubMed ID: 18579578
[TBL] [Abstract][Full Text] [Related]
17. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation.
Chauhan SK; Singh VV; Rai R; Rai M; Rai G
J Clin Immunol; 2013 Jul; 33(5):954-64. PubMed ID: 23564191
[TBL] [Abstract][Full Text] [Related]
18. Interferon score is increased in incomplete systemic lupus erythematosus and correlates with myxovirus-resistance protein A in blood and skin.
Lambers WM; de Leeuw K; Doornbos-van der Meer B; Diercks GFH; Bootsma H; Westra J
Arthritis Res Ther; 2019 Dec; 21(1):260. PubMed ID: 31791398
[TBL] [Abstract][Full Text] [Related]
19. Coronary heart disease in systemic lupus erythematosus is associated with interferon regulatory factor-8 gene variants.
Leonard D; Svenungsson E; Sandling JK; Berggren O; Jönsen A; Bengtsson C; Wang C; Jensen-Urstad K; Granstam SO; Bengtsson AA; Gustafsson JT; Gunnarsson I; Rantapää-Dahlqvist S; Nordmark G; Eloranta ML; Syvänen AC; Rönnblom L
Circ Cardiovasc Genet; 2013 Jun; 6(3):255-63. PubMed ID: 23661672
[TBL] [Abstract][Full Text] [Related]
20. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
